Previous Article | Next Article ![]()
Journal of Virology, January 2005, p. 1327-1332, Vol. 79, No. 2
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.2.1327-1332.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, Houston, Texas,1 Division of Infectious Diseases, School of Public Health, University of California, Berkeley, California,2 Department of Pediatrics,3 Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama4
Received 24 June 2004/ Accepted 23 August 2004
|
|
|---|
|
|
|---|
The SCPs are of great interest since they share the least sequence homology among the capsid proteins of herpesviruses (21). The other major and minor capsid proteins of the herpesviruses share relatively high sequence similarity, so the overall capsid structure is very similar among species, but the conformations, locations, and functions of the SCPs may be more diverse. The SCP of HCMV has been shown to be essential for HCMV infection in vivo (3), whereas its counterpart in HSV-1, VP26, is dispensable for HSV-1 infection (6, 10). In KSHV, although the presence of SCP (pORF65) is used as a hallmark of KSHV infection for diagnostic purposes, whether it is essential for KSHV infection remains unknown.
The HCMV SCP has been difficult to study because of its small size and because the inherent difficulties in culturing HCMV have limited the achievable resolution of its three-dimensional (3D) structure. Recent biochemical and immunoprecipitation studies by Lai and Britt confirmed that the SCP interacts specifically with the MCP (13). Based on architectural similarities, it was proposed that the HCMV SCP, like the SCPs of HSV-1 and KSHV (15, 19, 24), binds to MCP hexon subunits only (5, 7). However, these suggestions could not be verified by these structural studies because of the low resolutions (
35 Å) of the HCMV capsid maps. At such resolutions, protein boundaries cannot be resolved, and it is difficult to recognize structural features of proteins as small as SCP. In fact, even at 8.5-Å resolution, at which
-helices can be resolved, it has proven difficult to clearly delineate VP26 in HSV-1 hexons because of its extensive and interdigitated interactions across a large area of the MCP upper domain (23) and because its secondary structure consists mainly of ß-sheets (20). Because there are no reverse-engineering systems to generate an SCP-minus HCMV capsid for comparative structural studies as has been done with HSV-1 (19, 24), biochemical techniques, such as antibody labeling, seem to be the only available practical means by which to directly localize the HCMV SCP.
We have improved our HCMV purification and electron cryomicroscopy (cryoEM) imaging techniques such that we were able to obtain sufficient data to reconstruct the HCMV capsid to a higher resolution (22 Å) than previously achieved. Using anti-SCP antibody labeling, we show that the SCP of HCMV binds only to the tips of MCP hexon subunits.
Culture and imaging of HCMV capsids.
HCMV has been difficult to culture in sufficient quantities for high-resolution structural studies, since the capsids tend to aggregate within cellular debris. The standard HCMV capsid purification protocol (11) involves growing human foreskin fibroblasts to 90% confluence, infecting them with very-high-multiplicity-of-infection HCMV stocks (
5 particles/cell), lysing them to release the nuclei, and breaking the nuclei to release the capsids. We improved on this protocol by resuspending the capsids in a 1% solution of NP-40 and sonicating mildly with a Branson probe to dislodge the capsids from the debris before purifying and concentrating them. HCMV-infected cells collected from a total of 20 two-liter roller bottles were used to generate about 40 µl of concentrated HCMV capsids for the experiments in this study.
To generate the antibody-labeled HCMV capsids, we added a fivefold excess of purified monoclonal anti-SCP antibody (11.2.23; 1 mg/ml) (12) to 20 µl of capsid sample and incubated it overnight at 4°C. We used negative-stain electron microscopy with 2% uranyl acetate to evaluate the extent of antibody labeling by observing capsid cross-linkage and aggregation caused by the dual Fab arms of the antibodies. The antibody-labeled capsids were centrifuged in a desktop Eppendorf centrifuge at 13,000 x g for 20 min to remove unbound antibodies and concentrate the capsids. The sample was then resuspended in phosphate-buffered saline and sonicated in a water bath for 30 s to loosen the aggregated capsids.
We used established cryoEM procedures to image the capsids (1). Briefly, 3 µl of purified sample was applied to holey grids and quickly frozen in liquid ethane, such that the capsids were suspended in a thin layer of vitreous ice across the holes of the supporting film. Focal-pair image frames were acquired using a 200-kV JEOL 2010F electron microscope with a field emission gun. This microscope was also equipped with a Gatan US4000 4k- by 4k-pixel charge-coupled device (CCD) camera, which allows us to obtain more image data from a single sample of ice-embedded capsids than is possible using a microscope with a traditional film-loaded camera. Digital cryoEM images were recorded at an effective magnification of 83,100x on the CCD (60,000x on the film plane), corresponding to an effective pixel size of 1.805 Å/pixel at the specimen level, with a specimen dosage of approximately 12 electrons/Å2/micrograph. Focal-pair 4k- by 4k-pixel CCD images were recorded and preprocessed for translation and rotation correction using the JAMES semiautomatic data collection program (1). The electron beam was underfocused, with a 1.5-µm difference between the close-to-focus (
1 µm under focus) and far-from-focus (
2.5 µm under focus) images. For data processing, all images were averaged by combining adjacent pixels to yield a final sampling size of 3.61 Å/pixel on the specimen scale.
The micrographs of unlabeled HCMV capsids (Fig. 1A) show clean, evenly spaced capsids. In contrast, the antibody-labeled capsids (Fig. 1B) are surrounded by rings of capsid-bound antibodies and interspersed with clumps that may consist of antibodies nonspecifically bound to debris. The antibodies appear to completely surround the capsids, suggesting that most or all of the binding sites on the capsid surface were successfully saturated.
![]() View larger version (74K): [in a new window] |
FIG. 1. CryoEM micrographs of purified HCMV capsids. (A) Unlabeled capsids. (B) Capsids labeled with monoclonal anti-SCP antibodies, visible as clumps of density surrounding the capsids.
|
10-Å structure, the antibody-labeled capsid was reconstructed only to 22 Å because the flexible antibody densities would have been averaged out and would not be as clearly visible at a higher resolution.
![]() View larger version (152K): [in a new window] |
FIG. 2. 3D reconstructions of HCMV anti-SCP labeled and unlabeled capsids at 22-Å resolution. For clarity, the structures are colored according to radius (see color bar), so densities at different radial distances from the particle center are colored differently. (A) Antibody-labeled capsid, with antibody-attributed densities colored in purple. (B) Unlabeled capsid. (C) Close-up of boxed area from panel A. Antibody-attributed densities are attached only to MCP subunits of hexons (H), not pentons (arrow). (D) Another close-up clearly showing attachment of antibody to tip of hexon subunit.
|
![]() View larger version (89K): [in a new window] |
FIG. 3. Thin slices and difference mapping of unlabeled and antibody-labeled HCMV capsids. (A) Central slice down the twofold axis of the antibody-labeled (left) and unlabeled (right) HCMV capsid structures from Fig. 2. Extra densities attributed to bound antibodies are visible as a discontinuous ring around the capsid (left). (B) Difference map confirming the binding of anti-SCP antibodies to hexons but not pentons. The 3D structure of the unlabeled capsid (Fig. 2B) was subtracted from that of the labeled capsid (Fig. 2A), and the difference map (red densities) was superimposed onto the structure of the unlabeled capsid. (C and D) Contour maps showing close-up of twofold slice of unlabeled (D) and antibody-labeled (C) capsids. Antibody-attributed densities bound to hexons (H) but not pentons (P) can be seen.
|
Implications of SCPs in viral specificity. The SCPs of human herpesviruses have several common features: they are small and highly basic, and they decorate the surface of the capsid by binding to MCP subunits of hexons. However, they are highly variable across different herpesviruses (Fig. 4) and appear to have different functions in regard to capsid assembly and infection. In HSV-1, VP26 is not essential for capsid assembly or replication in vitro (6, 8, 10, 17), but it is required for production of infectious virus in vivo (10). In HCMV, the SCP is required for viral infection in vitro (3). The overall capsid structure of the channel catfish virus, a distant relative of the human herpesviruses, is almost identical to that of the other herpesviruses despite the absence of an SCP homolog (2), suggesting that the protein does not contribute to the overall organization of the capsid. The binding of SCP to the tips of the HCMV hexons suggests that it may be involved in interactions with the viral tegument, although previous structural studies have shown that the HCMV tegument proteins bind both hexons and pentons (7).
![]() View larger version (26K): [in a new window] |
FIG. 4. Sequence alignment of HSV-1, HCMV, and KSHV SCPs. CLUSTALW (18) yielded a poor alignment between the HSV-1 VP26 (GenBank accession number P10219), HCMV SCP (GenBank accession number AAR31612), and KSHV pORF65 (GenBank accession number NP_572121) sequences. The average sequence identity among the three SCP homologs was 15.9%, as computed using the program ALIGN (16).
|
It is also not clear why SCP binds only to hexons and not to pentons. This may be related to local differences between MCP subunits in pentons and hexons, such as differences in packing or electrochemical properties. The MCP of HSV-1, VP5, has been shown to have different electrochemical properties in pentons and hexons (4). The key region of VP26 that has been shown to interact with VP5 (9) contains basic residues that may interact with an acidic polyproline loop in the VP5 upper domain (4). A similar mechanism may be at work in HCMV, as the sequence in SCP that has been found to interact with MCP (13) also contains basic residues. An atomic model of the HCMV MCP upper domain and a subnanometer-resolution HCMV capsid map revealing the MCP-SCP interface will be required to identify the corresponding SCP-interacting residues. All these questions await further investigation. Nevertheless, it can be said that the herpesvirus SCPs are unique capsid proteins that represent an unusual example in which a protein evolves extensively in its amino acid sequence, 3D structure, and function while preserving its architectural property of binding to a specific partner in a specific oligomeric state.
We thank Yong-Hwan Kim for providing an HCMV virion stock and Zhenming Zhao for assistance during the initial cell culture for HCMV capsid isolation. We acknowledge the use of the cryoEM facility at the National Center for Macromolecular Imaging directed by Wah Chiu (supported by NIH grant P41RR02250).
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»